Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer

Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer

Multidrug resistance (MDR) is one of the major clinical challenges in cancer treatment and compromises the effectiveness of conventional anticancer chemotherapeutics. Among known mechanisms of drug resistance, drug efflux via ATP binding cassette (ABC) transporters, namely P-glycoprotein (P-gp) has...

Full description

Bibliographic Details
Main Authors:	Sabesan Yoganathan, Anushan Alagaratnam, Nikita Acharekar, Jing Kong
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Cells
Subjects:	anticancer drugs cancer multidrug resistance polyphenols ellagic acid schisandrin
Online Access:	https://www.mdpi.com/2073-4409/10/2/458

Similar Items

In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice
by: Dorota Nieoczym, et al.
Published: (2023-08-01)

Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of <i>Punica granatum</i> L.
by: Ralitza Alexova, et al.
Published: (2023-04-01)

Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC‐MS/MS
by: Shuanghu Wang, et al.
Published: (2023-05-01)

Ellagic Acid from Hull Blackberries: Extraction, Purification, and Potential Anticancer Activity
by: Jialuan Wang, et al.
Published: (2023-10-01)

The Effect of Schisandrin B on the Development of Multiple Sclerosis
by: Mustafa Cakir, et al.
Published: (2019-12-01)

Prevention of the Pro-Aggressive Effects of Ethanol-Intoxicated Mice by Schisandrin B
by: Ho Yin Pekkle Lam, et al.
Published: (2023-04-01)

Supplementation of Schisandrin B in Semen Extender Improves Quality and Oxidation Resistance of Boar Spermatozoa Stored at 4 °C
by: Yunfa Xie, et al.
Published: (2023-02-01)

Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis
by: Zhiman Li, et al.
Published: (2021-11-01)

Novel discovery of schisandrin A regulating the interplay of autophagy and apoptosis in oligoasthenospermia by targeting SCF/c-kit and TRPV1 via biosensors
by: Lijuan Ma, et al.
Published: (2023-06-01)

Involvement of PI3K/Akt/β-catenin signaling in schisandrin B-mitigated bone deterioration in an experimental rat model of estrogen deficiency
by: Yimin Liang, et al.
Published: (2020-02-01)

Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
by: Wu Luo, et al.
Published: (2022-11-01)

The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production
by: Chun-Ming Chang, et al.
Published: (2024-01-01)

Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer’s disease
by: Tian-tian Zhao, et al.
Published: (2023-02-01)

Albendazole-Schisandrin B Co-Therapy on <i>Angiostrongylus cantonensis</i>-Induced Meningoencephalitis in Mice
by: Ho Yin Pekkle Lam, et al.
Published: (2020-07-01)

Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
by: Hongwei Shi, et al.
Published: (2021-11-01)

HPLC-DAD optimization of quantification of vescalagin, gallic and ellagic acid in chestnut tannins
by: Charline Richard-Dazeur, et al.
Published: (2023-08-01)

Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid
by: Alessandro Ratti, et al.
Published: (2023-06-01)

Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry
by: Ajit Kumar, et al.
Published: (2021-08-01)

Targeting Myeloperoxidase Activity and Neutrophil ROS Production to Modulate Redox Process: Effect of Ellagic Acid and Analogues
by: Gilles Degotte, et al.
Published: (2023-06-01)

Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice
by: Xiaohu Wang, et al.
Published: (2023-09-01)

Preventive Effects of Schisandrin A, A Bioactive Component of <i>Schisandra chinensis</i>, on Dexamethasone-Induced Muscle Atrophy
by: MyeongHoon Yeon, et al.
Published: (2020-04-01)

Schisandrin C Affects Glucose-Stimulated Insulin Secretion in Pancreatic β-Cells and Glucose Uptake in Skeletal Muscle Cells
by: Dahae Lee, et al.
Published: (2021-10-01)

Research Progress of Extraction, Purification and Bioactivity of Ellagic Acid
by: Jialuan WANG, et al.
Published: (2022-07-01)

The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art
by: Guangying Lu, et al.
Published: (2023-09-01)

Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway
by: Wang Cuiqiong, et al.
Published: (2020-01-01)

Ellagic acid for oral mucositis: investigation of the therapeutic effect in rats
by: Ezgi Eroğlu Çakmakoğlu, et al.
Published: (2023-12-01)

The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages
by: Zhixin Wu, et al.
Published: (2024-03-01)

Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence
by: Martina Čižmáriková, et al.
Published: (2023-11-01)

Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
by: Rafael Madrigal-Chávez, et al.
Published: (2023-05-01)

Vitamin C and Phenolic Antioxidants of Jua (<i>Ziziphus joazeiro</i> M.) Pulp: A Rich Underexplored Brazilian Source of Ellagic Acid Recovered by Aqueous Ultrasound-Assisted Extraction
by: Thaís Silva da Rocha, et al.
Published: (2022-01-01)

Layered Double Hydroxide Nanoparticles to Overcome the Hydrophobicity of Ellagic Acid: An Antioxidant Hybrid Material
by: Szabolcs Muráth, et al.
Published: (2020-02-01)

Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax
by: Yanwu Hu, et al.
Published: (2021-01-01)

Assessment of ellagic acid action in 5-fluorouracil induced intestinal mucositis
by: Dareen Al-hoshary, et al.
Published: (2023-11-01)

Protective Effects of Ellagic Acid on Testicular Ischemia-Reperfusion Injury in Rats
by: Çağrı Akın Şekerci, et al.
Published: (2023-06-01)

Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds
by: Tomohiro Nabekura
Published: (2010-05-01)

The Protective effect of Ellagic acid on rats’ ovarian fetus toxicity induced by cyclophosphamide
by: M Mousavi M, et al.
Published: (2015-10-01)

The Use of Ellagic Acid and Annona Muricata Improves Semen Quality in Men with High-Risk Papillomavirus Infection
by: Sandro La Vignera, et al.
Published: (2022-08-01)

Schisandrin ameliorates diabetic nephropathy via regulating of PI3K/Akt/NF-κB-mediated inflammation and TGF-β1-induced fibrosis in HFD/STZ-induced C57BL/6J mice
by: Yu-zhuo Zhang, et al.
Published: (2023-01-01)

Effect of Punicalagin and Ellagic Acid on Human Fibroblasts In Vitro: A Preliminary Evaluation of Their Therapeutic Potential
by: Rebeca Illescas-Montes, et al.
Published: (2023-12-01)

Fermentative Liberation of Ellagic Acid from Walnut Press Cake Ellagitannins
by: Wolfram M. Brück, et al.
Published: (2022-10-01)